PT2729004T - Tratamento de acidúria metilmalónica, acidúria isovalérica, e outras acidúrias orgânicas com tocotrienol quinonas - Google Patents

Tratamento de acidúria metilmalónica, acidúria isovalérica, e outras acidúrias orgânicas com tocotrienol quinonas

Info

Publication number
PT2729004T
PT2729004T PT128077351T PT12807735T PT2729004T PT 2729004 T PT2729004 T PT 2729004T PT 128077351 T PT128077351 T PT 128077351T PT 12807735 T PT12807735 T PT 12807735T PT 2729004 T PT2729004 T PT 2729004T
Authority
PT
Portugal
Prior art keywords
aciduria
treatment
isovaleric
methylmalonic
tocotrienol quinones
Prior art date
Application number
PT128077351T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Ptc Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ptc Therapeutics Inc filed Critical Ptc Therapeutics Inc
Publication of PT2729004T publication Critical patent/PT2729004T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT128077351T 2011-07-06 2012-07-05 Tratamento de acidúria metilmalónica, acidúria isovalérica, e outras acidúrias orgânicas com tocotrienol quinonas PT2729004T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161505051P 2011-07-06 2011-07-06

Publications (1)

Publication Number Publication Date
PT2729004T true PT2729004T (pt) 2020-06-08

Family

ID=47437452

Family Applications (1)

Application Number Title Priority Date Filing Date
PT128077351T PT2729004T (pt) 2011-07-06 2012-07-05 Tratamento de acidúria metilmalónica, acidúria isovalérica, e outras acidúrias orgânicas com tocotrienol quinonas

Country Status (6)

Country Link
US (3) US20150057363A1 (https=)
EP (1) EP2729004B1 (https=)
JP (3) JP6728520B2 (https=)
ES (1) ES2795798T3 (https=)
PT (1) PT2729004T (https=)
WO (1) WO2013006737A1 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005033092A1 (en) 2003-09-19 2005-04-14 Galileo Pharmaceuticals, Inc. Chroman derivatives
EP2471530B1 (en) 2005-06-01 2017-01-11 Edison Pharmaceuticals, Inc. Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US9278085B2 (en) 2006-02-22 2016-03-08 Edison Pharmaceuticals, Inc. Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
WO2009061744A2 (en) 2007-11-06 2009-05-14 Edison Pharmaceuticals, Inc. 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
EA023618B1 (ru) 2008-01-08 2016-06-30 Эдисон Фармасьютикалз, Инк. Производные (гет)арил-п-хинона для лечения митохондриальных болезней
WO2009111576A2 (en) 2008-03-05 2009-09-11 Edison Pharmaceuticals, Inc. 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES
WO2009158348A1 (en) 2008-06-25 2009-12-30 Edison Pharmaceuticals, Inc. 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
EP2344142B1 (en) 2008-09-10 2024-06-26 PTC Therapeutics, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics
EP2362726B1 (en) 2008-10-14 2018-08-08 Bioelectron Technology Corporation Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells
CA2741767C (en) 2008-10-28 2017-09-12 Ptc Therapeutics, Inc. Process for the production of alpha-tocotrienol and derivatives
PL2424495T3 (pl) 2009-04-28 2018-06-29 Bioelectron Technology Corporation Leczenie dziedzicznej neuropatii nerwów wzrokowych lebera i dominującego zaniku nerwu wzrokowego chinonami tokotrienolu
WO2012174286A1 (en) 2011-06-14 2012-12-20 Edison Pharmaceuticals, Inc. Catechol derivatives for treatment of oxidative stress diseases
JP2014520894A (ja) 2011-07-19 2014-08-25 エジソン ファーマシューティカルズ， インコーポレイテッド 非アルファトコトリエノールの存在下でのアルファトコトリエノールの選択的酸化のための方法
CA2883879A1 (en) 2012-09-07 2014-03-13 Edison Pharmaceuticals, Inc. Quinone derivatives for use in the modulation of redox status of individuals
US9296712B2 (en) 2013-03-15 2016-03-29 Edison Pharmaceuticals, Inc. Resorufin derivatives for treatment of oxidative stress disorders
US9670170B2 (en) 2013-03-15 2017-06-06 Bioelectron Technology Corporation Resorufin derivatives for treatment of oxidative stress disorders
US10189830B2 (en) 2013-03-15 2019-01-29 Bioelectron Technology Corporation Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders
US9868711B2 (en) 2013-03-15 2018-01-16 Bioelectron Technology Corporation Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
AU2015364640B2 (en) 2014-12-16 2020-08-13 Ptc Therapeutics, Inc. Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
EP3390377B1 (en) 2015-12-16 2026-03-25 PTC Therapeutics, Inc. Improved methods for enriching alpha-tocotrienol from mixed tocol compositions
WO2017106803A1 (en) 2015-12-17 2017-06-22 Bioelectron Technology Corporation Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
WO2017184583A1 (en) * 2016-04-19 2017-10-26 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Anaplerotic agents for treatment of disorders of propionate and long chain fat metabolism
JP2018083799A (ja) 2016-11-15 2018-05-31 バイオエレクトロン テクノロジー コーポレイション ２−置換アミノ−ナフト［１，２−ｄ］イミダゾール−５−オン化合物またはその製薬学上許容される塩
KR20210076956A (ko) 2018-10-17 2021-06-24 피티씨 테라퓨틱스, 인크. α-시누클레인병증, 타우병증 및 기타 장애를 억제 및 치료하기 위한 2,3,5-트리메틸-6-노닐사이클로헥사-2,5-디엔-1,4-디온
EP3937922A4 (en) * 2019-03-14 2022-11-30 Hemoshear Therapeutics, Inc. Methods of treating organic acidemias
WO2021007350A1 (en) * 2019-07-09 2021-01-14 Icagen, Llc Bcat modulation
PE20240893A1 (es) 2021-07-08 2024-04-24 Ptc Therapeutics Inc Composiciones farmaceuticas que comprenden 2,3,5-trimetil-6-nonilciclohexa-2,5-dien-1,4-diona

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0204232D0 (en) 2002-02-22 2002-04-10 Isis Innovation Assay
DE60211875T2 (de) 2002-07-01 2006-10-26 Santhera Pharmaceuticals (Schweiz) Ag Screeningverfahren und Verbindungen zur Behandlung von Friedreich ataxia
EP1587960A2 (en) * 2003-01-30 2005-10-26 Research Development Foundation Methods and compositions for analysis of mitochondrial-related gene expression
EP2471530B1 (en) * 2005-06-01 2017-01-11 Edison Pharmaceuticals, Inc. Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
EP1749552A1 (en) * 2005-07-29 2007-02-07 Neuropharma S.A. Use of collismycin and derivatives thereof as oxidative stress inhibitors
JP2012525397A (ja) * 2009-04-28 2012-10-22 エジソン ファーマシューティカルズ， インコーポレイテッド 眼科疾患を治療するためのトコトリエノールキノンの製剤
PL2424495T3 (pl) * 2009-04-28 2018-06-29 Bioelectron Technology Corporation Leczenie dziedzicznej neuropatii nerwów wzrokowych lebera i dominującego zaniku nerwu wzrokowego chinonami tokotrienolu
US20120289476A1 (en) * 2009-12-11 2012-11-15 Jay Allan Barth Methods for treating methylmalonic acidemia

Also Published As

Publication number Publication date
EP2729004A1 (en) 2014-05-14
ES2795798T3 (es) 2020-11-24
US20180303770A1 (en) 2018-10-25
JP2014528914A (ja) 2014-10-30
US20210145769A1 (en) 2021-05-20
EP2729004B1 (en) 2020-03-25
EP2729004A4 (en) 2014-11-19
JP2018030892A (ja) 2018-03-01
US20150057363A1 (en) 2015-02-26
WO2013006737A1 (en) 2013-01-10
JP6728520B2 (ja) 2020-07-22
JP2020029465A (ja) 2020-02-27

Similar Documents

Publication Publication Date Title
EP2729004A4 (en) TREATMENT OF METHYLMALONIC ZIDURIA, ISOVALERIANIC ACID ZAIDURIA AND OTHER ORGANIC AZIDURES WITH TOCOTRIENOL CHINONES
EP2744852A4 (en) PLASMA MODIFIED MEDICAL DEVICES AND METHODS
SG11201402525YA (en) Catheter devices and techniques
ZA201409215B (en) Macrocyclic inhibitors of flaviviridae viruses
IL236005A0 (en) Macrocyclic inhibitors of flavoviride viruses
IL236006A0 (en) Macrocyclic inhibitors of flavoviride viruses
ZA201406969B (en) Combination therapy with an anti-hyaluronan agent and a tumor-targreted taxane
EP2939701A4 (en) CATHETER BALLOON, CATHETER AND METHOD FOR MANUFACTURING CATHETER BALLOON
EP2742033A4 (en) FLAVONOID COMPOUNDS AND METHODS OF USE
SG11201400370RA (en) Catheter balloon and balloon catheter
GB201208599D0 (en) Gas bearing spindles and gas bearing assemblies for gas bearing spindles
SG11201402654TA (en) Drug-coated medical devices
SG11201504805PA (en) Porcine parvovirus 5a, methods of use and vaccine
PL2885004T3 (pl) Kompozycja zawierająca dihydrokwercetynę, alfa-tokoferol i bisabolol
IL230988A0 (en) Combinations of corroles and statins
EP2768331A4 (en) PROTECTIVE DEVICES, COMPONENTS THEREFOR AND METHODS OF USE THEREOF
SI2678011T1 (sl) Protitumorska kombinacija, ki vsebuje kabazitaksel in cisplatin
IL232673A0 (en) Neurological treatments with metalloporphyrin
PL2846806T3 (pl) Leczenie depresji oddechowej
GB201207907D0 (en) Treatment of depression
ZA201402580B (en) Gaming devices and methods of operating them
GB2496516B (en) High chair and wheel assembly thereof
PL397633A1 (pl) Nowy 5-hydroksy-6,7-dipropionoksyflawon i sposób jego wytwarzania
GB201120194D0 (en) Medical implant and assembly including tabs with openings
AU2011903218A0 (en) Flavonoid compounds, and methods of use thereof